Inhibition of interleukin-12 expression by α-thrombin in human peripheral blood mononuclear cells: A potential mechanism for modulating Th1/ Th2 responses

British Journal of Pharmacology

Volumn 140, Issue 5, 2003, Pages 980-986

  Naldini, A ^a   Aarden, L ^b   Pucci, A ^a   Bernini, C ^a   Carraro, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cytokine; Inflammation; Mononuclear cells; Protease activated receptor; Thrombin

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; MONOCLONAL ANTIBODY; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; BLOOD CLOTTING; BLOOD CULTURE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNITY; INFLAMMATION; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; TH1 CELLS; TH2 CELLS; THROMBIN;

EID: 0344010040     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705514     Document Type: Article

References (43)

1. ASOKANANTHAN, N., GRAHAM, P.T., FINK, J., KNIGHT, D.A., BARKER, A.J., MCWILLIAM, A.S., THOMPSON, P.J. & STEWART, G.A. (2002). Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E(2) release from human respiratory epithelial cells. J. Immunol., 168, 3577-3585.
2. BUTENAS, S., VAN'T VEER, C. & MANN, K.G. (1999). 'Normal' thrombin generation. Blood, 94, 2169-2178.
3. CAVALLO, F., QUAGLINO, E., CIFALDI, L., DI CARLO, E., ANDRE, A., BERNABEI, P., MUSIANI, P., FORNI, G. & CALOGERO, R.A. (2001). Interleukin 12-activated lymphocytes influence tumor genetic programs. Cancer Res., 61, 3518-3523.
4. CIRINO, G., BUCCI, M., CICALA, C. & NAPOLI, C. (2000). Inflammation-coagulation network: are serine protease receptors the knot? Trends Pharmacol. Sci., 21, 170-172.
5. CIRINO, G., CICALA, C., BUCCI, M.R., SORRENTINO, L., MARAGANORE, J.M. & STONE, S.R. (1996). Thrombin functions as an inflammatory mediator through activation of its receptor. J. Exp. Med., 183, 821-827.
6. COLOTTA, F., SCIACCA, F.L., SIRONI, M., LUINI, W., RABIET, M.J. & MANTOVANI, A. (1994). Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am. J. Pathol., 144, 975-985.
7. CUNNINGHAM, M.A., RONDEAU, E., CHEN, X., COUGHLIN, S.R., HOLDSWORTH, S.R. & TIPPING, P.G. (2000). Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J. Exp. Med., 191, 455-462.
8. D'ANDREA, A., ASTE-AMEZAGA, M., VALIANTE, N.M., MA, X., KUBIN, M. & TRINCHIERI, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med., 178, 1041-1048.
9. DEL PRETE, G., DE CARLI, M., LAMMEL, R.M., D'ELIOS, M.M., DANIEL, K.C., GIUSTI, B., ABBATE, R. & ROMAGNANI, S. (1995). ThI and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood, 86, 250-257.
10. DEL PRETE, G., MAGGI, E. & ROMAGNANI, S. (1994). Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab. Invest., 70, 299-306.
11. GRAND, R.J.A., TURNELL, A.S. & GRABHAM, P.W. (1996). Cellular consequences of thrombin-receptor activation. Biochem. J., 313, 353-368.
12. GRIFFIN, C.T., SRINIVASAN, Y., ZHENG, Y.W., HUANG, W. & COUGHLIN, S.R. (2001). A role for thrombin receptor signaling in endothelial cells during embryonic development. Science, 293, 1666-1670.
13. HOWELLS, G.L., MACEY, M., CURTIS, M.A. & STONE, S.R. (1993). Peripheral blood lymphocytes express the platelet-type thrombin receptor. Br. J. Haematol., 84, 156-160.
14. ISHIHARA, H., CONNOLLY, A.J., ZENG, D., KAHN, M.L., ZHENG, Y.-W., TIMMONS, C., TRAM, T. & COUGHLIN, S.R. (1997). Protease-activated receptor 3 is a second thrombin receptor in humans. Nature, 386, 502-506.
15. JANSEN, P.M., VAN DER POUW KRAAN, T.C., DE JONG, I.W., VAN MIERLO, G., WIJDENES, J., AARDEN, L., CHANG, A.A., TAYLOR JR, F.B. & HACK, C.E. (1996). The release of interleukin-12 in Escherichia coli-induced lethal and sublethal primate sepsis. Ann. N.Y. Acad. Sci., 795, 351-353.
16. JOHNSON, K., AARDEN, L., CHOI, Y., DE GROOT, E. & CREASEY, A. (1996). The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood, 87, 5051-5060.
17. JOHNSON, K., CHOI, Y., DEGROOT, E., SAMUELS, I., CREASEY, A. & AARDEN, L. (1998). Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J. Immunol., 160, 5130-5135.
18. KAHN, M.L., ZHENG, Y.-W., HUANG, W., BIGORNIA, V., ZENG, D., MOFF, S., FARESE JR, R.V., TAM, C. & COUGHLIN, S.R. (1998). A dual thrombin receptor system for platelet activation. Nature, 394, 690-694.
19. KAUR, J., WOODMAN, R.C., OSTROVSKY, L. & KUBES, P. (2001). Selective recruitment of neutrophils and lymphocytes by thrombin: a role for NF-kappaB. Am. J. Physiol. Heart Circ. Physiol., 281, H784-H795.
20. LAUW, F.N., DEKKERS, P.E., TE VELDE, A.A., SPEELMAN, P., LEVI, M., KURIMOTO, M., HACK, C.E., VAN DEVENTER, S.J. & VAN DER, P.T. (1999). Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J. Infect. Dis., 179, 646-652.
21. MINNEMA, M.C., CHANG, A.C., JANSEN, P.M., LUBBERS, Y.T., PRATT, B.M., WHITTAKER, B.C., TAYLOR, F.B., HACK, C.E. & FRIEDMAN, B. (2000). Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli. Blood, 95, 1117-1123.
22. MOORE, K.W., DE WAAL, M.R., COFFMAN, R.L. & O'GARRA, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol., 19, 683-765.
23. NALDINI, A. & CARNEY, D.H. (1996). Thrombin modulation of natural killer activity in human peripheral lymphocytes. Cell Immunol., 172, 35-42.
24. NALDINI, A., CARNEY, D.H., BOCCI, V., KLIMPEL, K.D., ASUNCION, M., SOARES, L.E. & KLIMPEL, G.R. (1993). Thrombin enhances T cell proliferative responses and cytokine production. Cell. Immunol., 147, 367-377.
25. NALDINI, A., CARNEY, D.H., PUCCI, A., PASQUALI, A. & CARRARO, F. (2002). Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen. Pharmacol., 35, 255-259.
26. NALDINI, A., SOWER, L.E., BOCCI, V., MEYERS, B. & CARNEY, D.H. (1998). Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation. J. Cell. Physiol., 177, 76-84.
27. O'GARRA, A. & ARAI, N. (2000). The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol., 10, 542-550.
28. ROMAGNANI, P., ANNUNZIATO, F., PICCINNI, M.P., MAGGI, E. & ROMAGNANI, S. (2000). Th1/Th2 cells, their associated molecules and role in pathophysiology. Eur. Cytokine Network, 11, 510-511.
29. ROMAGNANI, S. (1997). The Th1/Th2 paradigm. Immunol. Today, 18, 263-266.
30. SCHMIDLIN, F. & BUNNETT, N.W. (2001). Pro tease-activated receptors: how proteases signal to cells. Curr. Opin. Pharmacol., 1, 575-582.
31. SCHWACHA, M.G., CHUNG, C.S., AYALA, A., BLAND, K.I. & CHAUDRY, I.H. (2002). Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury. Am. J. Physiol. Cell Physiol., 282, C263-C270.
32. h1 cells. Immunol. Today, 14, 335-338.
33. TRINCHIERI, G. (1998). Proinflammatory and immunoregulatory functions of interleukin-12. Int. Rev. Immunol., 16, 365-396.
34. TSOPANOGLOU, N.E. & MARAGOUDAKIS, M.E. (1999). On the mechanism of thrombin-induced angiogenesis: potentiation of vascular endothelial gowth factor activity on endothelial cells by upregulation of its receptor. J. Biochem., 274, 23969-23976.
35. TSOPANOGLOU, N.E., PIPILI-SYNETOS, E. & MARAGOUDAKIS, M.E. (1993). Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am. J. Physiol., 264, C1302-C1307.
36. VAN DER POUW KRAAN, T.C., BOEIJE, L.C., SMEENK, R.J., WIJDENES, J. & AARDEN, L.A. (1995). Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med., 181, 775-779.
37. VAN DER POUW KRAAN, T.C., SNIJDERS, A., BOEIJE, L.C., DE GROOT, E.R., ALEWIJNSE, A.E., LEURS, R. & AARDEN, L.A. (1998). Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J. Clin. Invest., 102, 1866-1873.
38. VERGNOLLE, N., WALLACE, J.L., BUNNETT, N.W. & HOLLENBERG, M.D. (2001). Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol. Sci., 22, 146-152.
39. VOEST, E.E., KENYON, B.M., O'REILLY, M.S., TRUITT, G., D'AMATO, R.J. & FOLKMAN, J. (1995). Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst., 87, 581-586.
40. VU, T.-K.H., HUNG, D.T., WHEATON, V.I. & COUGHLIN, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 1057-1068.
41. WHITE, B. & PERRY, D. (2001). Acquired antithrombin deficiency in sepsis. Br. J. Haematol., 112, 26-31.
42. WIGGINTON, J.M., GRUYS, E., GEISELHART, L., SUBLESKI, J., KOMSCHLIES, K.L., PARK, J.W., WILTROUT, T.A., NAGASHIMA, K., BACK, T.C. & WILTROUT, R.H. (2001). IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/ pulse 1L-2 therapy. J. Clin. Invest., 108, 51-62.
43. WOODMAN, R.C., TEOH, D., PAYNE, D. & KUBES, P. (2000). Thrombin and leukocyte recruitment in endotoxemia. Am. J. Physiol. Heart Circ. Physiol., 279, H1338-H1345.